ClinicalTrials.gg

Program

SHR8554

A development code. Also written as “SHR8554 Injection”, “SHR8554 Injection and SHR0410 Injection” and “SHR8554;Itraconazole”.

Its studies are mostly in Pain · Pain, Postoperative, led by Jiangsu HengRui Medicine.

Furthest: phase 3, since Feb 9, 20216 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Jiangsu HengRui Medicine60 open or runningphase 3since Feb 9, 2021Feb 9, 2021none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 9, 2021First study: phase 3 study in PainFirst studyNCT04766463 · 528 enrolled · China
  2. Mar 9, 2021Phase 3 study in PainNCT04794738 · 192 enrolled · China
  3. May 11, 2022Phase 3 study in PainNCT05375305 · 320 enrolled · China
  4. Jul 20, 2022Phase 2 study in PainNCT05470049 · 108 enrolled
  5. Jun 26, 2023Phase 1 study in HealthyNCT05928988 · 17 enrolled · China
  6. Sep 17, 2025Phase 1 study in Moderate to Severe Postoperative PainNCT07189962 · 20 enrolled · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07189962Moderate to Severe Postoperative Pain · China1CompletedApr 13, 202320
NCT05928988Healthy · China1CompletedJan 21, 202217
NCT05470049Pain2UNKNOWNNov 1, 2022108
NCT05375305Pain · China3CompletedOct 19, 2023320
NCT04794738Pain · China3UNKNOWNOct 30, 2021192
NCT04766463Pain · China3CompletedOct 19, 2021528

How it is read

Names in the registry

  • “SHR8554 Injection”, 5 entries
  • “SHR8554 Injection and SHR0410 Injection”, 2 entries
  • “SHR8554”, 2 entries
  • “SHR8554;Itraconazole”, 1 entry

Codes read as this program: SHR8554.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.